ABCG8, UGT1A1 and Gallstone Disease After Bariatric Surgery

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorEsbjerg Hospital - University Hospital of Southern Denmark

About this trial

The goal of this observational genetic case-control study is to learn whether two specific genetic variants in ABCG8 and UGT1A1 are associated with gallstone disease after bariatric surgery. The study includes adults who have previously undergone bariatric surgery.

The main questions it aims to answer are whether the ABCG8 D19H variant and the UGT1A1 rs6742078 variant are associated with an increased risk of gallstone disease requiring cholecystectomy after bariatric surgery.

Researchers will compare patients who underwent bariatric surgery and later had their gallbladder removed because of gallstone disease with patients who underwent bariatric surgery but did not develop gallstone disease or undergo cholecystectomy during follow-up.

Participants will provide one blood sample for targeted genetic analysis and complete questionnaires about health, previous surgery, medication use, family history, and gastrointestinal quality of life. Relevant clinical information will also be collected from medical records.

Eligibility criteria

Qualifiers

Bariatric surgery

Disqualifiers

Gallstone disease or cholecystectomy prior to bariatric surgery

Trial design

Treatments tested in this trial

  • blood sampling

Treatment groups

270 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

Esbjerg Hospital - University Hospital of Southern Denmark

Lead sponsor

Odense University Hospital

Collaborator

University of Southern Denmark

Collaborator